The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis

被引：4

作者：

Quan, Liuliu ^{[1
,2
]}

Dai, Jiawen ^{[3
,4
]}

Luo, Yuan ^{[5
]}

Wang, Lin ^{[6
]}

Liu, Yue ^{[5
]}

Meng, Jiaqi ^{[5
]}

Yang, Fan ^{[5
]}

You, Xin ^{[2
,7
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Med Oncol, Beijing, Peoples R China

[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Shuaifuyuan 1, Beijing 100730, Peoples R China

[3] Tianjin Inst Hlth Sci, Tianjin, Peoples R China

[4] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst,, Tianjin, Peoples R China

[5] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China

[6] Southwest Med Univ, Sch Clin Med, Luzhou, Peoples R China

[7] Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China

来源：

HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2024年 / 20卷 / 01期

关键词：

Systemic lupus erythematosus; citations; bibliometric analysis; literature review; bibliometrics; research hotspots; B-LYMPHOCYTE STIMULATOR; RECEPTOR MONOCLONAL-ANTIBODY; RHEUMATOLOGY DAMAGE INDEX; GENOME-WIDE ASSOCIATION; DISEASE-ACTIVITY INDEX; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE-DISEASES; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; ANTICARDIOLIPIN ANTIBODIES;

D O I：

10.1080/21645515.2024.2387461

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Systemic lupus erythematosus (SLE) is an autoimmune inflammatory tissue disease. In view of the explosive growth in research on SLE, bibliometrics was performed to evaluate the 100 top-cited papers in this realm. We performed the search with terms "systemic lupus erythematosus" the Web of Science Core Collection database on May 3, 2023. Relevant literatures were screened. Data were extracted and analyzed by SPSS. The citations of 100 top-cited SLE studies spanned from 472 to 13,557. Most studies (60 out of 100) were conducted in the United States. Total citation times were positively associated with ACY, which was negatively correlated with the length of time since publication. Approximately half of the studies focused on the underlying mechanisms of SLE. New biologic therapies garnered attention and development. Our findings provide valuable insights into the developments in crucial areas of SLE and shed contributions to future studies.

引用

页数：16

共 140 条

[41]

2-I

[42] NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS [J].

ESTES, D ;

CHRISTIAN, CL .

MEDICINE, 1971, 50 (02) :85-+

[43] 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus [J].

Fanouriakis, Antonis ;

Kostopoulou, Myrto ;

Alunno, Alessia ;

Aringer, Martin ;

Bajema, Ingeborg ;

Boletis, John N. ;

Cervera, Ricard ;

Doria, Andrea ;

Gordon, Caroline ;

Govoni, Marcello ;

Houssiau, Frederic ;

Jayne, David ;

Kouloumas, Marios ;

Kuhn, Annegret ;

Larsen, Janni L. ;

Lerstrom, Kirsten ;

Moroni, Gabriella ;

Mosca, Marta ;

Schneider, Matthias ;

Smolen, Josef S. ;

Svenungsson, Elisabet ;

Tesar, Vladimir ;

Tincani, Angela ;

Troldborg, Anne ;

van Vollenhoven, Ronald ;

Wenzel, Joerg ;

Bertsias, George ;

Boumpas, Dimitrios T. .

ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (06) :736-745

[44] NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS - DIAGNOSIS, CLINICAL SPECTRUM, AND RELATIONSHIP TO OTHER FEATURES OF DISEASE [J].

FEINGLASS, EJ ;

ARNETT, FC ;

DORSCH, CA ;

ZIZIC, TM ;

STEVENS, MB .

MEDICINE, 1976, 55 (04) :323-339

[45] DEFECTIVE RETICULOENDOTHELIAL SYSTEM FC-RECEPTOR FUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].

FRANK, MM ;

HAMBURGER, MI ;

LAWLEY, TJ ;

KIMBERLY, RP ;

PLOTZ, PH .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (10) :518-523

[46] ANIFROLUMAB, AN ANTI-INTERFERON-ALPHA RECEPTOR MONOCLONAL ANTIBODY, IN MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) [J].

Furie, R. ;

Merrill, J. T. ;

Werth, V. P. ;

Khamashta, M. ;

Kalunian, K. ;

Brohawn, P. ;

Illei, G. ;

Drappa, J. ;

Wang, L. ;

Yoo, S. .

ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 :168-168

[47] Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus [J].

Furie, Richard ;

Khamashta, Munther ;

Merrill, Joan T. ;

Werth, Victoria P. ;

Kalunian, Kenneth ;

Brohawn, Philip ;

Illei, Gabor G. ;

Drappa, Jorn ;

Wang, Liangwei ;

Yoo, Stephen .

ARTHRITIS & RHEUMATOLOGY, 2017, 69 (02) :376-386

[48] A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus [J].

Furie, Richard ;

Petri, Michelle ;

Zamani, Omid ;

Cervera, Ricard ;

Wallace, Daniel J. ;

Tegzova, Dana ;

Sanchez-Guerrero, Jorge ;

Schwarting, Andreas ;

Merrill, Joan T. ;

Chatham, W. Winn ;

Stohl, William ;

Ginzler, Ellen M. ;

Hough, Douglas R. ;

Zhong, Z. John ;

Freimuth, William ;

van Vollenhoven, Ronald F. .

ARTHRITIS AND RHEUMATISM, 2011, 63 (12) :3918-3930

[49] Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases [J].

Gabriel, Sherine E. ;

Michaud, Kaleb .

ARTHRITIS RESEARCH & THERAPY, 2009, 11 (03)

[50] Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs [J].

Gadina, Massimo ;

Johnson, Catrina ;

Schwartz, Daniella ;

Bonelli, Michael ;

Hasni, Sarfaraz ;

Kanno, Yuka ;

Changelian, Paul ;

Laurence, Arian ;

O'Shea, John J. .

JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 104 (03) :499-514

← 1 2 3 4 5 6 7 8 9 10 →